# Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)

> **NCT01887379** · PHASE1 · COMPLETED · sponsor: **LTS Lohmann Therapie-Systeme AG** · enrollment: 10 (actual)

## Conditions studied

- Gastroretentive Drug Formulation of Furosemide
- Oedema

## Interventions

- **DRUG:** GRDF furosemide

## Key facts

- **NCT ID:** NCT01887379
- **Lead sponsor:** LTS Lohmann Therapie-Systeme AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887379, "Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01887379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*